| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 2.25e-05 | 6 | 25 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 3.15e-05 | 7 | 25 | 2 | GO:0050291 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 9.69e-05 | 196 | 25 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.06e-04 | 74 | 25 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | transporter activity | 1.18e-04 | 1289 | 25 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.39e-04 | 81 | 25 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.75e-04 | 23 | 25 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.31e-04 | 119 | 25 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.68e-04 | 296 | 25 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 6.84e-04 | 31 | 25 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | symporter activity | 8.46e-04 | 150 | 25 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.24e-03 | 171 | 25 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.85e-03 | 51 | 25 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.42e-03 | 775 | 25 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.49e-03 | 465 | 25 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.73e-03 | 477 | 25 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 3.17e-03 | 238 | 25 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.10e-03 | 301 | 25 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 7.18e-03 | 102 | 25 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.21e-03 | 627 | 25 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 8.79e-03 | 664 | 25 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.38e-02 | 758 | 25 | 4 | GO:0015318 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.41e-02 | 1180 | 25 | 5 | GO:0022857 | |
| GeneOntologyBiologicalProcess | alpha-ketoglutarate transport | 2.95e-05 | 7 | 25 | 2 | GO:0015742 | |
| GeneOntologyBiologicalProcess | phosphatidylserine exposure on apoptotic cell surface | 9.24e-05 | 12 | 25 | 2 | GO:0070782 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 1.47e-04 | 15 | 25 | 2 | GO:0043652 | |
| GeneOntologyCellularComponent | apical part of cell | 3.93e-07 | 592 | 26 | 8 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.60e-06 | 487 | 26 | 7 | GO:0016324 | |
| Domain | NA_SULFATE | 5.16e-06 | 3 | 25 | 2 | PS01271 | |
| Domain | Na/sul_symport_CS | 5.16e-06 | 3 | 25 | 2 | IPR031312 | |
| Domain | Na/sul_symport | 1.72e-05 | 5 | 25 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 1.72e-05 | 5 | 25 | 2 | PF00939 | |
| Domain | Lag1/Lac1 | 2.57e-05 | 6 | 25 | 2 | IPR016439 | |
| Domain | XK-related | 9.39e-05 | 11 | 25 | 2 | PF09815 | |
| Domain | XK_rel | 9.39e-05 | 11 | 25 | 2 | IPR018629 | |
| Domain | TLC | 2.04e-04 | 16 | 25 | 2 | PS50922 | |
| Domain | TLC-dom | 2.04e-04 | 16 | 25 | 2 | IPR006634 | |
| Domain | TLC | 2.04e-04 | 16 | 25 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 2.04e-04 | 16 | 25 | 2 | PF03798 | |
| Domain | - | 2.03e-03 | 50 | 25 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 2.72e-03 | 58 | 25 | 2 | IPR008983 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.25e-06 | 76 | 18 | 4 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.37e-06 | 84 | 18 | 4 | M27334 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 1.54e-05 | 5 | 18 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 1.54e-05 | 5 | 18 | 2 | M27354 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.01e-04 | 238 | 18 | 4 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.39e-04 | 249 | 18 | 4 | M5988 | |
| Pathway | WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES | 3.50e-04 | 22 | 18 | 2 | M45544 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 4.54e-04 | 25 | 18 | 2 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 4.91e-04 | 26 | 18 | 2 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 4.91e-04 | 26 | 18 | 2 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 5.30e-04 | 27 | 18 | 2 | M39863 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 5.30e-04 | 27 | 18 | 2 | MM14646 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 6.56e-04 | 30 | 18 | 2 | M39501 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 9.99e-04 | 37 | 18 | 2 | M554 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 9.99e-04 | 37 | 18 | 2 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.11e-03 | 39 | 18 | 2 | M793 | |
| Pubmed | Ceramide synthesis regulates T cell activity and GVHD development. | 5.37e-07 | 2 | 26 | 2 | 28515365 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 38552027 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12912983 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23538298 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12297269 | ||
| Pubmed | Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. | 5.37e-06 | 5 | 26 | 2 | 15823095 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 26887952 | ||
| Pubmed | Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. | 5.37e-06 | 5 | 26 | 2 | 16211368 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 17977534 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 23936132 | ||
| Pubmed | Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. | 2.41e-05 | 10 | 26 | 2 | 25231987 | |
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 17382312 | ||
| Pubmed | 1.65e-04 | 143 | 26 | 3 | 20424473 | ||
| Pubmed | 1.86e-04 | 27 | 26 | 2 | 23096701 | ||
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 1.86e-04 | 27 | 26 | 2 | 25269881 | |
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 2.15e-04 | 29 | 26 | 2 | 38485951 | |
| Pubmed | 6.72e-04 | 231 | 26 | 3 | 21048031 | ||
| GeneFamily | CERS class homeoboxes | 1.40e-05 | 6 | 18 | 2 | 530 | |
| GeneFamily | Blood group antigens|XK related family | 5.12e-05 | 11 | 18 | 2 | 955 | |
| GeneFamily | Solute carriers | 5.39e-04 | 395 | 18 | 4 | 752 | |
| GeneFamily | Ring finger proteins | 3.00e-02 | 275 | 18 | 2 | 58 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.86e-06 | 154 | 26 | 4 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.86e-06 | 154 | 26 | 4 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.86e-06 | 154 | 26 | 4 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.86e-06 | 154 | 26 | 4 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | COVID-19-APC-like-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.96e-06 | 156 | 26 | 4 | 735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 168 | 26 | 3 | 93b7138f17aa14a6398c9b4ea7237781a0e19a66 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 168 | 26 | 3 | e393553208617a023f1646169c892a87c95db3f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 171 | 26 | 3 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 174 | 26 | 3 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 174 | 26 | 3 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 176 | 26 | 3 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 179 | 26 | 3 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 180 | 26 | 3 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 183 | 26 | 3 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 183 | 26 | 3 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 184 | 26 | 3 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 185 | 26 | 3 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 186 | 26 | 3 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 189 | 26 | 3 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 192 | 26 | 3 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 196 | 26 | 3 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 197 | 26 | 3 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 198 | 26 | 3 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-04 | 198 | 26 | 3 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 200 | 26 | 3 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 200 | 26 | 3 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| Drug | 2-azaspiro[4.4]nonane | 1.16e-05 | 5 | 25 | 2 | CID000418904 | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 6712_UP | |
| Drug | 2-methyl-3-phenylpropionamide | 7.49e-05 | 75 | 25 | 3 | CID000348285 | |
| Drug | ketorolac tromethamine | 1.20e-04 | 15 | 25 | 2 | CID000084003 | |
| Drug | ketorolac | 1.96e-04 | 19 | 25 | 2 | CID000003826 | |
| Drug | metoprolol | 2.04e-04 | 105 | 25 | 3 | CID000004171 | |
| Drug | GdCl3 | 2.09e-04 | 106 | 25 | 3 | CID000061486 | |
| Drug | calyculin A | 2.59e-04 | 114 | 25 | 3 | ctd:C059041 | |
| Drug | fluo-3 | 3.17e-04 | 122 | 25 | 3 | CID000104978 | |
| Drug | hypothiocyanite | 3.42e-04 | 25 | 25 | 2 | CID000124984 | |
| Drug | 2-aminoethyl diphenylborinate | 3.56e-04 | 127 | 25 | 3 | CID000001598 | |
| Drug | Succinic acid | 3.70e-04 | 26 | 25 | 2 | DB00139 | |
| Drug | oxcarbazepine | 4.94e-04 | 30 | 25 | 2 | CID000034312 | |
| Drug | 1-methyladenosine | 5.99e-04 | 33 | 25 | 2 | CID000027476 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 6.99e-04 | 160 | 25 | 3 | 6133_DN | |
| Drug | Kodak CD4 | 7.53e-04 | 37 | 25 | 2 | CID000075383 | |
| Drug | carbamazepine | 9.68e-04 | 179 | 25 | 3 | CID000002554 | |
| Drug | fura-2 acetoxymethyl ester | 1.06e-03 | 44 | 25 | 2 | CID003364574 | |
| Drug | lissamine | 1.06e-03 | 44 | 25 | 2 | CID005359521 | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 5.80e-06 | 5 | 23 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 1.62e-05 | 8 | 23 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 8.45e-05 | 110 | 23 | 3 | EFO_0803335 | |
| Disease | sphingomyelin measurement | 1.27e-03 | 278 | 23 | 3 | EFO_0010118 | |
| Disease | white matter microstructure measurement | 3.33e-03 | 390 | 23 | 3 | EFO_0005674 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WWYLLELGFYLSLLI | 181 | Q9HA82 | |
| RKWWGLNLQFLLVFL | 716 | P41180 | |
| LQALGLLWFRYHNLW | 251 | Q9NRD8 | |
| MLWRQLIYWQLLALF | 1 | Q9BXJ4 | |
| VFAWLLQYARGLWLA | 26 | O14523 | |
| QFWSGLKLFRNILLW | 646 | P16383 | |
| LWYIIGIQFLLLWLV | 1081 | P54289 | |
| LQWPLSYLAIFWILQ | 16 | Q58HT5 | |
| WWVFNLLLLLVQGLN | 301 | Q6ZMG9 | |
| FWNLLWYFQRLRLPS | 1301 | O75064 | |
| LGSLYFLRFLQWKWL | 166 | Q15835 | |
| LLALVGYLIRDWRWL | 246 | Q9Y694 | |
| LLLSWIWLQWLFLGF | 296 | Q9BZW2 | |
| AWLWLQILFLGFNFR | 281 | Q13183 | |
| IGLLWALLLNWYLTV | 56 | P59544 | |
| LGNVYFWLQLLLWRL | 126 | A6NC51 | |
| GRWLLLRLALFGFLW | 6 | Q9UK23 | |
| LFWEQYIGLRHWLLL | 1016 | Q13635 | |
| AWEFNALLLLQLLGW | 81 | P53794 | |
| LAVQGWFLLQLHWRL | 51 | O43557 | |
| LYGQILDWLRYLVAW | 296 | Q8N4F7 | |
| YGQLLDWLRYLVAWQ | 296 | Q9H920 | |
| ALLVFLSLLGWILWY | 76 | C9JI98 | |
| VIYFLWNLLLLWPRV | 201 | Q9H6D3 | |
| ALFLLLFLWLLGIIW | 231 | Q5GH70 | |
| LSLFLFLWFILGNYW | 111 | A0A1B0GTI8 |